Streamline Health Solutions, Inc.

Informe Stock NasdaqCM:STRM

Capitalización de mercado: US$18.8m

Streamline Health Solutions Crecimiento futuro

Future controles de criterios 1/6

Streamline Health Solutions se prevé un crecimiento anual de los beneficios y los ingresos de 32% y 10.7%, respectivamente, mientras que el BPA aumentará de grow a 34.8%.

Información clave

71.8%

Tasa de crecimiento de los beneficios

73.6%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare Services27.4%
Tasa de crecimiento de los ingresos11.5%
Rentabilidad financiera futuran/a
Cobertura de analistas

Low

Última actualización15 Feb 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Revenues Working Against Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Share Price Following 26% Dive

Jan 26
Revenues Working Against Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Share Price Following 26% Dive

Revenue Downgrade: Here's What Analysts Forecast For Streamline Health Solutions, Inc. (NASDAQ:STRM)

Dec 16
Revenue Downgrade: Here's What Analysts Forecast For Streamline Health Solutions, Inc. (NASDAQ:STRM)

Would Streamline Health Solutions (NASDAQ:STRM) Be Better Off With Less Debt?

Dec 07
Would Streamline Health Solutions (NASDAQ:STRM) Be Better Off With Less Debt?

Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Intrinsic Value Is Potentially 76% Above Its Share Price

Oct 04
Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Intrinsic Value Is Potentially 76% Above Its Share Price

Would Streamline Health Solutions (NASDAQ:STRM) Be Better Off With Less Debt?

Sep 07
Would Streamline Health Solutions (NASDAQ:STRM) Be Better Off With Less Debt?

There's Reason For Concern Over Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Price

Jul 26
There's Reason For Concern Over Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Price

Health Check: How Prudently Does Streamline Health Solutions (NASDAQ:STRM) Use Debt?

Jan 31
Health Check: How Prudently Does Streamline Health Solutions (NASDAQ:STRM) Use Debt?

Streamline Health GAAP EPS of -$0.07 in-line, revenue of $5.99M beats by $0.79M

Sep 07

Streamline Health rallies after signing new contract with care delivery client based in Southwest

Jul 20

We Think Streamline Health Solutions (NASDAQ:STRM) Has A Fair Chunk Of Debt

Jun 08
We Think Streamline Health Solutions (NASDAQ:STRM) Has A Fair Chunk Of Debt

Streamline Health Solutions (NASDAQ:STRM) Has Debt But No Earnings; Should You Worry?

Feb 11
Streamline Health Solutions (NASDAQ:STRM) Has Debt But No Earnings; Should You Worry?

Need To Know: This Analyst Just Made A Substantial Cut To Their Streamline Health Solutions, Inc. (NASDAQ:STRM) Estimates

Dec 11
Need To Know: This Analyst Just Made A Substantial Cut To Their Streamline Health Solutions, Inc. (NASDAQ:STRM) Estimates

Streamline Health Solutions, Inc. Is A Massive Medical SaaS Opportunity

Dec 03

Is Streamline Health Solutions (NASDAQ:STRM) A Risky Investment?

Jul 27
Is Streamline Health Solutions (NASDAQ:STRM) A Risky Investment?

Streamline Health Solutions, Inc. 2021 Q1 - Results - Earnings Call Presentation

Jun 09

Is Streamline Health Solutions (NASDAQ:STRM) Using Debt Sensibly?

Dec 11
Is Streamline Health Solutions (NASDAQ:STRM) Using Debt Sensibly?

Streamline Health Solutions, Inc. 2020 Q3 - Results - Earnings Call Presentation

Dec 10

Previsiones de crecimiento de beneficios e ingresos

NasdaqCM:STRM - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
1/31/202728N/A4N/A1
1/31/202624N/A2N/A1
1/31/202522-7-2N/A2
1/31/202423-20-18N/A2
10/31/202324-20-7-5N/A
7/31/202324-11-7-5N/A
4/30/202324-11-8-6N/A
1/31/202325-11-9-7N/A
10/31/202224-9-6-5N/A
7/31/202223-10-7-5N/A
4/30/202220-7-6-5N/A
1/31/202217-7-5-4N/A
10/31/202114-9-5-3N/A
7/31/202111-5-4-3N/A
4/30/202111-6-3-2N/A
1/31/202111-5-8-6N/A
10/31/202011-6-7-5N/A
7/31/202012-1-7-4N/A
4/30/202012-2-7-5N/A
1/31/202012-1-30N/A
10/31/201915-2-21N/A
7/31/201916-6-21N/A
4/30/201919-6-12N/A
1/31/201922-6-21N/A
10/31/201823-303N/A
7/31/201824-213N/A
4/30/201825-214N/A
1/31/201824-302N/A
10/31/201725-4-11N/A
7/31/201725-6N/A0N/A
4/30/201726-6N/A2N/A
1/31/201727-6N/A1N/A
10/31/201627-7N/A1N/A
7/31/201628-6N/A5N/A
4/30/201629-5N/A4N/A
1/31/201628-6N/A6N/A
10/31/201529-9N/A3N/A
7/31/201528-11N/A2N/A
4/30/201527-12N/A0N/A
1/31/201528-13N/A-3N/A
10/31/201428-10N/A-3N/A
7/31/201427-14N/A-3N/A
4/30/201429-13N/A-1N/A
1/31/201428-13N/A0N/A
10/31/201329-18N/A-2N/A
7/31/201329-9N/A-5N/A
4/30/201325-9N/A-4N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: STRM se prevé que siga sin ser rentable en los próximos 3 años.

Beneficios frente mercado: STRM se prevé que siga sin ser rentable en los próximos 3 años.

Beneficios de alto crecimiento: STRM se prevé que siga sin ser rentable en los próximos 3 años.

Ingresos vs. Mercado: STRMSe prevé que los ingresos de la empresa (10.7% al año) crezcan más deprisa que los del mercado US (8.1% al año).

Ingresos de alto crecimiento: STRMSe prevé que los ingresos de la empresa (10.7% al año) crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la Rentabilidad de los fondos propios de STRM se prevé elevada dentro de 3 años.


Descubre empresas en crecimiento

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target